Form 4 for PHVS Pharvaris N.V.
Accepted 2026-05-13 18:48:55 ET · period of report 2026-05-11 · accession 0001193125-26-222163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-13 18:48 | 2026-05-11+ | PHVS | Lu Peng | Chief Medical Off | F - Tax | $30.02 | -226 | 65.9K | -0.3% | -$6,784 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-11 | F | D | 109 | $30.09 | 65,974 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units on May 11, 2026. The shares were withheld on May 11, 2026 at a fair market value of $30.09 per share. |
| 2 | Common | Common Stock | 2026-05-12 | F | D | 117 | $29.95 | 65,857 | D | — | — | (F2) Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units on May 12, 2026. The shares were withheld on May 12, 2026 at a fair market value of $29.95 per share. |